Cargando…

The Impact of Immunofunctional Phenotyping on the Malfunction of the Cancer Immunity Cycle in Breast Cancer

SIMPLE SUMMARY: The cancer-immunity cycle (CIC) is a series of self-sustaining stepwise events to fight cancer growth by the immune system. We hypothesized that immunofunctional phenotyping that represent the malfunction of the CIC is clinically relevant in breast cancer (BC) utilizing total of 2979...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takeshita, Takashi, Torigoe, Toshihiko, Yan, Li, Huang, Jing Li, Yamashita, Hiroko, Takabe, Kazuaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795596/ https://www.ncbi.nlm.nih.gov/pubmed/33396390 http://dx.doi.org/10.3390/cancers13010110

Ejemplares similares

Detection and evaluation of immunofunction of patients with severe fever with thrombocytopenia syndrome
por: Sun, Liping, et al.
Publicado: (2013)

Late recurrence of breast cancer is associated with pro-cancerous immune microenvironment in the primary tumor
por: Takeshita, Takashi, et al.
Publicado: (2019)

Measurement of immunofunctional leptin to detect and monitor patients with functional leptin deficiency
por: Wabitsch, Martin, et al.
Publicado: (2016)

Biologically Aggressive Phenotype and Anti-cancer Immunity Counterbalance in Breast Cancer with High Mutation Rate
por: Takahashi, Hideo, et al.
Publicado: (2020)

Development of a Machine Learning-Based Prognostic Model for Hormone Receptor-Positive Breast Cancer Using Nine-Gene Expression Signature
por: Takeshita, Takashi, et al.
Publicado: (2023)

APOBEC3-Mediated RNA Editing in Breast Cancer is Associated with Heightened Immune Activity and Improved Survival
por: Asaoka, Mariko, et al.
Publicado: (2019)

Cancer immunohistogram representing cancer-immunity cycle by immunohistochemistry predicts the efficacy of immune checkpoint inhibitors in urological cancer patients
por: Kijima, Toshiki, et al.
Publicado: (2022)

Neoadjuvant Chemotherapy for Breast Cancer: Past, Present, and Future
por: Asaoka, Mariko, et al.
Publicado: (2020)

Clinical Relevance of Estrogen Reactivity in the Breast Cancer Microenvironment
por: Takeshita, Takashi, et al.
Publicado: (2022)

High MYC mRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast Cancer
por: Katsuta, Eriko, et al.
Publicado: (2019)

Si-ni-tang (a Chinese herbal formula) for improving immunofunction in sepsis: study protocol for a pilot randomized controlled trial
por: Zeng, Ruifeng, et al.
Publicado: (2019)

Clinical Impact of Sphingosine-1-Phosphate in Breast Cancer
por: Tsuchida, Junko, et al.
Publicado: (2017)

Ventilator malfunction
por: Krishna Kumar, BR, et al.
Publicado: (2011)

Malfunction defended
por: Sullivan-Bissett, Ema
Publicado: (2016)

Enhanced immune response outperform aggressive cancer biology and is associated with better survival in triple-negative breast cancer
por: Oshi, Masanori, et al.
Publicado: (2022)

Enhanced Thermogenesis in Triple-Negative Breast Cancer Is Associated with Pro-Tumor Immune Microenvironment
por: Gandhi, Shipra, et al.
Publicado: (2021)

Intra-Tumoral Angiogenesis Is Associated with Inflammation, Immune Reaction and Metastatic Recurrence in Breast Cancer
por: Oshi, Masanori, et al.
Publicado: (2020)

High expression of bone morphogenetic protein (BMP) 6 and BMP7 are associated with higher immune cell infiltration and better survival in estrogen receptor-positive breast cancer
por: Katsuta, Eriko, et al.
Publicado: (2019)

Contribution of Immune Cells to Glucocorticoid Receptor Expression in Breast Cancer
por: Gandhi, Shipra, et al.
Publicado: (2020)

Octogenarians’ Breast Cancer Is Associated with an Unfavorable Tumor Immune Microenvironment and Worse Disease-Free Survival
por: Okano, Maiko, et al.
Publicado: (2021)

G2M Cell Cycle Pathway Score as a Prognostic Biomarker of Metastasis in Estrogen Receptor (ER)-Positive Breast Cancer
por: Oshi, Masanori, et al.
Publicado: (2020)

High Expression of NRF2 Is Associated with Increased Tumor-Infiltrating Lymphocytes and Cancer Immunity in ER-Positive/HER2-Negative Breast Cancer
por: Oshi, Masanori, et al.
Publicado: (2020)

YTHDC2 Promotes Malignant Phenotypes of Breast Cancer Cells
por: Tanabe, Atsushi, et al.
Publicado: (2022)

Vaporizer interlock malfunctioning
por: Doctor, Jeson R, et al.
Publicado: (2016)

Adipogenesis in triple-negative breast cancer is associated with unfavorable tumor immune microenvironment and with worse survival
por: Oshi, Masanori, et al.
Publicado: (2021)

Management of Male Breast Cancer: The Journey so Far and Future Directions
por: Sabih, Quratulain (Anna), et al.
Publicado: (2021)

Pacemaker Malfunction During Passive Proton Beam Therapy for Localized Prostate Cancer: Case Reports and a Literature Review
por: Yoshida, Tsukasa, et al.
Publicado: (2023)

MYC Targets Scores Are Associated with Cancer Aggressiveness and Poor Survival in ER-Positive Primary and Metastatic Breast Cancer
por: Schulze, Amy, et al.
Publicado: (2020)

Mechano-Sensing Channel PIEZO2 Enhances Invasive Phenotype in Triple-Negative Breast Cancer
por: Katsuta, Eriko, et al.
Publicado: (2022)

CD8 T Cell Score as a Prognostic Biomarker for Triple Negative Breast Cancer
por: Oshi, Masanori, et al.
Publicado: (2020)

Concealed malfunction of the temporary pacemaker
por: Alasti, Mohammad, et al.
Publicado: (2006)

Risks due to UPS malfunctioning
por: Thiesen, H
Publicado: (2009)

Malfunctioning pilot balloon assembly
por: Baduni, Neha, et al.
Publicado: (2013)

Decreased Lipid Phosphate Phosphatase 1/3 and Increased Lipid Phosphate Phosphatase 2 Expression in the Human Breast Cancer Tumor Microenvironment Promotes Tumor Progression and Immune System Evasion
por: Benesch, Matthew G. K., et al.
Publicado: (2023)

Impact of Radiotherapy on Malfunctions and Battery Life of Cardiac Implantable Electronic Devices in Cancer Patients
por: Lisowski, Dominik, et al.
Publicado: (2023)

Left sided breast cancer is associated with aggressive biology and worse outcomes than right sided breast cancer
por: Abdou, Yara, et al.
Publicado: (2022)

Immune responses to human cancer stem‐like cells/cancer‐initiating cells
por: Hirohashi, Yoshihiko, et al.
Publicado: (2015)

Tamoxifen sensitivity-related microRNA-342 is a useful biomarker for breast cancer survival
por: Young, Jessica, et al.
Publicado: (2017)

Cytotoxic T-lymphocyte infiltration and chemokine predict long-term patient survival independently of tumor mutational burden in triple-negative breast cancer
por: Katsuta, Eriko, et al.
Publicado: (2021)

NR2F1, a Tumor Dormancy Marker, Is Expressed Predominantly in Cancer-Associated Fibroblasts and Is Associated with Suppressed Breast Cancer Cell Proliferation
por: Wu, Rongrong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_86pr6m0ln22ahj837233gti2oo